Update on Vaccine-Derived Polioviruses — Worldwide, January 2017–June 2018

Update on Vaccine-Derived Polioviruses — Worldwide, January 2016–June 2017

In 1988, the World Health Assembly launched the Global Polio Eradication Initiative (GPEI) (1). Among the three wild poliovirus (WPV) serotypes, only type 1 (WPV1) has been detected since 2012. Since 2014, detection of WPV1 has been limited to three countries, with 37 cases in 2016 and 11 cases in 2017 as of September 27. The >99.99% decline worldwide in polio cases since the launch of the GPEI...

Update on Vaccine-Derived Polioviruses — Worldwide, January 2014–March 2015

Since the World Health Assembly's 1988 resolution to eradicate poliomyelitis, one of the main tools of the World Health Organization (WHO) Global Polio Eradication Initiative (GPEI) has been the live, attenuated oral poliovirus vaccine (OPV). OPV might require several doses to induce immunity but provides long-term protection against paralytic disease. Through effective use of OPV, GPEI has bro...

Update on Vaccine-Derived Polioviruses — Worldwide, July 2012–December 2013

In 1988, the World Health Assembly resolved to eradicate poliomyelitis worldwide. One of the main tools used in polio eradication efforts has been live, attenuated oral poliovirus vaccine (OPV), an inexpensive vaccine easily administered by trained volunteers. OPV might require several doses to induce immunity, but then it provides long-term protection against paralytic disease through durable ...

Gaps in our knowledge about transmission of vaccine-derived polioviruses.

It has long been known that oral poliovirus vaccine (OPV) viruses are transmissible ¿to some degree¿ between vaccinated individuals and their contacts. This property has generally been considered an advantage of these vaccines, since it can spread immunity, despite the fact that the viruses sometimes revert to virulence and hence can also cause vaccine-attributable paralytic poliomyelitis in v...

ATUBES: January 2018